Human Gene Therapy - April 2023 - 324

324
SHELDON ET AL.
Advanced Breast Cancer and Melanoma. Poster
presented at American Association for Cancer
Research: San Antonio, TX; 2014.
41. Predina JD, Haas AR, Martinez M, et al.
Neoadjuvant gene-mediated cytotoxic immunotherapy
for non-small-cell lung cancer: Safety
and immunologic activity. Mol Ther 2021;29(2):
658-670.
42. Rosenthal EL, Chung TK, Parker WB, et al. Phase I
dose-escalating trial of Escherichia coli purine
nucleoside phosphorylase and fludarabine gene
therapy for advanced solid tumors. Ann Oncol
2015;26(7):1481-1487.
43. Seiwert TY, Darga T, Haraf D, et al. A phase I
dose escalation study of Ad GV.EGR.TNF.11D
(TNFerade Biologic) with concurrent chemoradiotherapy
in patients with recurrent head and
neck cancer undergoing reirradiation. Ann Oncol
2013;24(3):769-776.
44. Sung MW, Yeh HC, Thung SN, et al. Intratumoral
adenovirus-mediated suicide gene transfer for
hepatic metastases from colorectal adenocarcinoma:
Results of a phase I clinical trial. Mol Ther
2001;4(3):182-191.
45. Swisher SG, Roth JA, Nemunaitis J, et al.
Adenovirus-mediated p53 gene transfer in advanced
non-small-cell lung cancer. J Natl Cancer
Inst 1999;91(9):763-771.
46. Swisher SG, Roth JA, Komaki R, et al. Induction of
p53-regulated genes and tumor regression in lung
cancer patients after intratumoral delivery of adenoviral
p53 (INGN 201) and radiation therapy.
Clin Cancer Res 2003;9(1):93-101.
47. Teh BS, Aguilar-Cordova E, Kernen K, et al. Phase I/II
trial evaluating combined radiotherapy and in situ
gene therapywith or without hormonal therapy in the
treatment of prostate cancer-A preliminary report.
Int J Radiat Oncol Biol Phys 2001;51(3):605-613.
48. Yoo GH, Moon J, Leblanc M, et al. A phase 2 trial of
surgery with perioperative INGN 201 (Ad5CMV-p53)
gene therapy followed by chemoradiotherapy for
advanced, resectable squamous cell carcinoma of
the oral cavity, oropharynx, hypopharynx, and larynx:
Report of the Southwest Oncology Group. Arch
Otolaryngol Head Neck Surg 2009;135(9):869-874.
49. Wilson JM. Lessons learned from the gene therapy
trial for ornithine transcarbamylase deficiency.
Mol Genet Metab 2009;96(4):151-157.
50. Alter P, Herzum M, Soufi M, et al. Cardiotoxicity
of 5-fluorouracil. Cardiovasc Hematol Agents Med
Chem 2006;4(1):1-5.
51. Yi HJ, Hong KS, Moon N, et al. Acute hyperammonemic
encephalopathy after 5-fluorouracil
based chemotherapy. Ann Surg Treat Res 2016;
90(3):179-182.
52. Mitin T. Radiation Therapy Techniques in Cancer
Treatment. In: UpToDate (Loeffler JS, Vora SR.
ed.) Philadelphia, Pennsylvania. UpToDate; 2022.
Available from: https://www.uptodate.com/
contents/radiation-therapytechniques-in-cancertreatment
[Last accessed: February 22, 2022].
53. Koizumi N, Yamaguchi T, Kawabata K, et al. Fibermodified
adenovirus vectors decrease liver toxicity
through reduced IL-6 production. J Immunol 2007;
178(3):1767-1773.
Received for publication December 7, 2022;
accepted after revision February 15, 2023.
Published online: February 25, 2023.

https://www.uptodate.com/contents/radiation-therapytechniques-in-cancer-treatment https://www.uptodate.com/contents/radiation-therapytechniques-in-cancer-treatment https://www.uptodate.com/contents/radiation-therapytechniques-in-cancer-treatment

Human Gene Therapy - April 2023

Table of Contents for the Digital Edition of Human Gene Therapy - April 2023